MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Palbociclib dihydrochloride

CAS No. :

MCE 站：Palbociclib dihydrochloride

产品活性：Palbociclib (PD 0332991) dihydrochloride 是一种具有口服活性的 CDK4 和 CDK6 选择性抑制剂，IC₅₀ 值分别为 11 nM 和16 nM。Palbociclib dihydrochloride 对癌细胞具有抗增殖活性，并诱导其细胞周期阻滞，可用于 HR 阳性和 HER2 阴性乳腺癌，以及肝细胞癌的相关研究。

研究领域：Cell Cycle/DNA Damage

作用靶点：CDK

In Vitro: Palbociclib dihydrochloride (0-1 μM, 24 h) inhibits Rb Phosphorylation at Ser⁷⁹⁵ in MDA-MB-435 cells with an IC₅₀ value of 0.063 μM, ａnd obtains similar effects on both Ser⁷⁸⁰ ａnd Ser⁷⁹⁵ phosphorylation in the Colo-205 colon carcinoma.
Palbociclib dihydrochloride (0-10 μM, 24 h) arrests MDA-MB-453 cells exclusively in G1 phase.
Palbociclib dihydrochloride (500 nM, 7 days) increases expression of homologous genes (H2d1, H2k1, ａnd B2m) in MDA-MB-453 ａnd MDA-MB-361 cells.
Palbociclib dihydrochloride (0-1 μM, 6 days) inhibits growth of several luminal ER-positive as well as HER2-amplified breast cancer cell lines, with IC₅₀ values ranging from 4 nM to 1 μM.
Palbociclib dihydrochloride (0-1 μM, 3 days) inhibits the proliferation of human liver cancer cell lines with IC₅₀ values ranging from 0.01 μM to 3.49 μM, ａnd induces a reversible cell cycle arrest.

In Vivo: Palbociclib dihydrochloride (oral adminstration, 75 or 150 mg/kg, daily for 14 days) produces rapid tumor regressions ａnd delays tumor growth.
Palbociclib dihydrochloride (oral adminstration, 90 mg/kg, daily for 12 days) reduces Treg numbers ａnd the Treg:CD8 ratio in the spleen ａnd lymph nodes in tumor-free mice, demonstrating the tumor-independent effects.
Palbociclib dihydrochloride (oral administration, 100 mg/kg, daily for 1 week) has potent antitumour effects in genetically engineered mosaic mouse model of liver cancer.

相关产品：Palbociclib  |  Abemaciclib  |  Ro-3306  |  Dinaciclib  |  Ribociclib  |  THZ1  |  THZ531  |  Flavopiridol  |  Seliciclib  |  SR-4835  |  AZD4573  |  Fadraciclib  |  Simurosertib  |  NVP-2  |  SNS-032  |  (E/Z)-Zotiraciclib  |  AZD-5438  |  Kenpaullone  |  Wogonin  |  AT7519  |  KB-0742 dihydrochloride  |  SY-5609  |  NG 52  |  GSK 3 Inhibitor IX  |  Mevociclib  |  OTS964 hydrochloride

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  染料试剂  |  PROTAC  |  同位素标记物  |  寡核苷酸

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。